Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arlene Chapman

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|December 28, 2013
Renal relevant radiology: radiologic imaging in autosomal dominant polycystic kidney diseaseFrederic Rahbari-Oskoui, Ankush Mittal, Pardeep Mittal, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 28, 2025
Effect of Race on Transplantation in Autosomal Dominant Polycystic Kidney DiseaseSambhavi Krishnamoorthy, Niveditha Girimaji Satishchandra, Arlene Chapman, et al.
BMC Nephrology|February 27, 2019
Plasma metabolites and lipids associate with kidney function and kidney volume in hypertensive ADPKD patients early in the disease courseKyoungmi Kim, Josephine F Trott, Guimin Gao, et al.
Clinicoeconomics and Outcomes Research : CEOR|March 12, 2015
Medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer dataTyler Knight, Caroline Schaefer, Holly Krasa, et al.
Computational Statistics & Data Analysis|August 18, 2009
Reproducibility of Genotypes as Measured by the Affymetrix GeneChip® 100K Human Mapping Array SetBrooke L Fridley, Stephen T Turner, Arlene Chapman, et al.
Diabetes Care|April 13, 2007
Primary aldosteronism in diabetic subjects with resistant hypertensionGuillermo E Umpierrez, Paul Cantey, Dawn Smiley, et al.
Journal of the American Society of Nephrology : JASN|June 29, 2002
Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized studyRobert Schrier, Kimberly McFann, Ann Johnson, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 26, 2009
Nephrogenic systemic fibrosis versus contrast-induced nephropathy: risks and benefits of contrast-enhanced MR and CT in renally impaired patientsDiego R Martin, Richard C Semelka, Arlene Chapman, et al.
American Journal of Physiology. Renal Physiology|February 5, 2010
A metabolomics approach using juvenile cystic mice to identify urinary biomarkers and altered pathways in polycystic kidney diseaseSandra L Taylor, Sheila Ganti, Nikolay O Bukanov, et al.
Kidney Medicine|October 23, 2020
Alport Syndrome Classification and ManagementBradley A Warady, Rajiv Agarwal, Sripal Bangalore, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Clinical Journal of the American Society of Nephrology : CJASN|December 28, 2013
Renal relevant radiology: radiologic imaging in autosomal dominant polycystic kidney diseaseFrederic Rahbari-Oskoui, Ankush Mittal, Pardeep Mittal, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 28, 2025
Effect of Race on Transplantation in Autosomal Dominant Polycystic Kidney DiseaseSambhavi Krishnamoorthy, Niveditha Girimaji Satishchandra, Arlene Chapman, et al.
BMC Nephrology|February 27, 2019
Plasma metabolites and lipids associate with kidney function and kidney volume in hypertensive ADPKD patients early in the disease courseKyoungmi Kim, Josephine F Trott, Guimin Gao, et al.
Clinicoeconomics and Outcomes Research : CEOR|March 12, 2015
Medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer dataTyler Knight, Caroline Schaefer, Holly Krasa, et al.
Computational Statistics & Data Analysis|August 18, 2009
Reproducibility of Genotypes as Measured by the Affymetrix GeneChip® 100K Human Mapping Array SetBrooke L Fridley, Stephen T Turner, Arlene Chapman, et al.
Diabetes Care|April 13, 2007
Primary aldosteronism in diabetic subjects with resistant hypertensionGuillermo E Umpierrez, Paul Cantey, Dawn Smiley, et al.
Journal of the American Society of Nephrology : JASN|June 29, 2002
Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized studyRobert Schrier, Kimberly McFann, Ann Johnson, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 26, 2009
Nephrogenic systemic fibrosis versus contrast-induced nephropathy: risks and benefits of contrast-enhanced MR and CT in renally impaired patientsDiego R Martin, Richard C Semelka, Arlene Chapman, et al.
American Journal of Physiology. Renal Physiology|February 5, 2010
A metabolomics approach using juvenile cystic mice to identify urinary biomarkers and altered pathways in polycystic kidney diseaseSandra L Taylor, Sheila Ganti, Nikolay O Bukanov, et al.
Kidney Medicine|October 23, 2020
Alport Syndrome Classification and ManagementBradley A Warady, Rajiv Agarwal, Sripal Bangalore, et al.
Pageof 5